Company / Current Liabilities per Share
Bionano Genomics, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$12.30
FY2025
5-year range
$0.11 / $48.97
FY2021-FY2025
Trend
-74.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $3.37 to $12.30 over the past 2 years.
Based on SEC 10-K filings.
12.30 in FY2025 with a 5-year CAGR of +116.1%.
Increased from $3.37 to $12.30 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +363.0%
- 5-Year CAGR
- +116.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 74.9% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.30 | -74.9% |
| FY2024 | $48.97 | +1355.0% |
| FY2023 | $3.37 | +2616.5% |
| FY2022 | $0.12 | +7.8% |
| FY2021 | $0.11 | -55.9% |
| FY2020 | $0.26 | -90.0% |
| FY2019 | $2.62 | -95.5% |
| FY2018 | $58.54 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026